The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patterns of Twitter use among trainees in hematology-oncology related areas.
 
Miguel Gonzalez Velez
No Relationships to Disclose
 
Narjust Duma
Consulting or Advisory Role - Inivata
 
Daniel Cabrera
No Relationships to Disclose
 
Ariela L. Marshall
No Relationships to Disclose
 
Deanna J. Attai
No Relationships to Disclose
 
Merry Jennifer Markham
Research Funding - Aduro Biotech (Inst); Lilly (Inst); Novartis (Inst); Tesaro (Inst); VBL Therapeutics (Inst)
 
Rafael Fonseca
Stock and Other Ownership Interests - Adaptive Biotechnologies
Honoraria - Abbvie; Aduro Biotech; Amgen; Bayer; Bristol-Myers Squibb; Celgene; Janssen; Juno Therapeutics; Kite, a Gilead company; Merck Sharp & Dohme; OncoTracker; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Aduro Biotech; Amgen; Bayer; Bristol-Myers Squibb; Celgene; Janssen; Juno Therapeutics; Kite, a Gilead company; Merck Sharp & Dohme; OncoTracker; Sanofi; Takeda
Patents, Royalties, Other Intellectual Property - Dr Fonseca has received a patent for the prognostication of MM based on genetic categorization of the disease.
Travel, Accommodations, Expenses - Abbvie; Aduro Biotech; Amgen; Bayer; Bristol-Myers Squibb; Celgene; Janssen; Juno Therapeutics; Kite, a Gilead company; Merck Sharp & Dohme; OncoTracker; Sanofi; Takeda
Other Relationship - Adaptive Biotechnologies